Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Viruses
|
November 6, 2019
The First Complete Genome Sequences of Hepatitis C Virus Subtype 2b from Latin America: Molecular Characterization and Phylogeographic Analysis
Natália Spitz, José J Barros, Kycia M do Ó, et al.
BMC Microbiology
|
January 24, 2008
Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil
Marcelle Bottecchia, Francisco J D Souto, Kycia M R O, et al.
AIDS (London, England)
|
August 30, 2008
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy
Mário Guimarães Pessôa, Brian Gazzard, Anna K Huang, et al.
Plos One
|
May 8, 2019
Treatment of chronic HCV infection with DAAs in Rio de Janeiro/Brazil: SVR rates and baseline resistance analyses in NS5A and NS5B genes
Vanessa D Costa, Carlos E Brandão-Mello, Estevão P Nunes, et al.
Annals of Internal Medicine
|
April 22, 2009
Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial
Donald M Jensen, Patrick Marcellin, Bradley Freilich, et al.
Immunology
|
February 1, 2017
The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C
Fabio C O F Cachem, Aleida S Dias, Clarice Monteiro, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
March 9, 2019
How are HCV-infected patients being identified in Brazil: a multicenter study
Luiz H Portari-Filho, Mario R Álvares-da-Silva, Aline Gonzalez, et al.
Annals of Hepatology
|
January 3, 2019
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis
Mario G Pessoa, José V Ramalho-Madruga, Katia Alves, et al.
Critical Care Medicine
|
June 1, 2026
Does the Frailty Burden Impact ICU Performance Indicators Benchmarking? A Multicenter Cohort Study Using Two Severity-of-Illness Scores
Leonardo S L Bastos, Gaston Burghi, Carlos E Brandão, et al.
Journal of Hepatology
|
April 8, 2023
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Homie A Razavi, Maria Buti, Norah A Terrault, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Viruses
|
November 6, 2019
The First Complete Genome Sequences of Hepatitis C Virus Subtype 2b from Latin America: Molecular Characterization and Phylogeographic Analysis
Natália Spitz, José J Barros, Kycia M do Ó, et al.
BMC Microbiology
|
January 24, 2008
Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil
Marcelle Bottecchia, Francisco J D Souto, Kycia M R O, et al.
AIDS (London, England)
|
August 30, 2008
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy
Mário Guimarães Pessôa, Brian Gazzard, Anna K Huang, et al.
Plos One
|
May 8, 2019
Treatment of chronic HCV infection with DAAs in Rio de Janeiro/Brazil: SVR rates and baseline resistance analyses in NS5A and NS5B genes
Vanessa D Costa, Carlos E Brandão-Mello, Estevão P Nunes, et al.
Annals of Internal Medicine
|
April 22, 2009
Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial
Donald M Jensen, Patrick Marcellin, Bradley Freilich, et al.
Immunology
|
February 1, 2017
The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C
Fabio C O F Cachem, Aleida S Dias, Clarice Monteiro, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
March 9, 2019
How are HCV-infected patients being identified in Brazil: a multicenter study
Luiz H Portari-Filho, Mario R Álvares-da-Silva, Aline Gonzalez, et al.
Annals of Hepatology
|
January 3, 2019
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis
Mario G Pessoa, José V Ramalho-Madruga, Katia Alves, et al.
Critical Care Medicine
|
June 1, 2026
Does the Frailty Burden Impact ICU Performance Indicators Benchmarking? A Multicenter Cohort Study Using Two Severity-of-Illness Scores
Leonardo S L Bastos, Gaston Burghi, Carlos E Brandão, et al.
Journal of Hepatology
|
April 8, 2023
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Homie A Razavi, Maria Buti, Norah A Terrault, et al.
Page
of 1